A biomarker is the measure of an indicator of a medical condition in the human body. Biomarkers can be measured in biological media such as blood, tissues, or cells. They are usedas diagnostic tools, or are parameters that aid in the understanding of the progression of a disease, or the cause, diagnosis, progression, or outcome of the treatment of a disease. An imaging biomarker is a biomarker, or biological feature, detectable in an image that has been generated using imaging technology. Imaging biomarkers have grown both in quantity and complexity as medical imaging has expanded its applications to various imaging modalities.

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape

15.1 Competitive Scenario

15.1.1 Key News

15.1.2 Mergers and Acquisitions

15.2 Key Vendors

15.3 Market Share Analysis 2013

16. Key Vendor Analysis

16.1 Abbott Laboratories

16.1.1 Business Overview

16.1.2 Business Segmentation

16.1.3 Key Information

16.1.4 SWOT Analysis

16.2 Affymetrix Inc.

16.2.1 Business Overview

16.2.2 Business Segmentation

16.2.3 Key Information

16.2.4 SWOT Analysis

16.3 Bio-Rad Laboratories Inc.

16.3.1 Business Overview

16.3.2 Business Segmentation

16.3.3 Key Information

16.3.4 SWOT Analysis

16.4 F. Hoffmann La Roche Ltd.

16.4.1 Business Overview

16.4.2 Business Segmentation

16.4.3 Key Information

16.4.4 SWOT Analysis

16.5 Siemens Healthcare

16.5.1 Business Overview

16.5.2 Key Information

16.5.3 SWOT Analysis

17. Other Reports in this Series